Narayana Hrudayalaya Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹2,594Cr
- +75.9% YoY
- +20.6% QoQ
- Net profit
- ₹224Cr
- +13.7% YoY
- +76.4% QoQ
- Margin
- 20%
- −4 pp YoY
- +3 pp QoQ
Guidance rank: #27 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
The short version
Clinic business to be integrated with hospital business from FY27, reflecting better contribution measurement. Narayana Hrudayalaya is in an expansion phase, investing heavily (USD 100 million capex; INR 3,000 crores planned in India) to fuel growth, which may dilute short-term ROCE/ROE but is expected to be accretive long-term.
From Narayana Hrudayalaya Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Clinic business to be integrated with hospital business from FY27, reflecting better contribution measurement.
- Focus on domestic patients to replace international patient volumes, with no active international marketing currently.
- Investment in digital marketing, integrated care, clinics, insurance, and strengthening clinical teams expected to drive volume growth in Eastern region within 2-3 quarters.
- No immediate expansion plans in North and West clusters; focus on expanding adult programs in existing Mumbai SRCC hospital.
- Clinics serve as initial patient contact points, expected to shift patient preference from hospitals to clinics, supporting hospital expansion.
- ARPP (Average Revenue per Patient) growth anticipated through advanced procedures and case mix optimization.
2 more points from Narayana Hrudayalaya Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Narayana Hrudayalaya Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- FY26 greenfield capex was INR 109 crores, lower than the planned INR 424 crores, mainly due to election-related labor shortages and delays in permissions; FY28 commissioning timeline for Rajarhat, HSR, Raipur, Bangalore still on track.
- Total proposed capex for projects is INR 3,000 crores, with greenfield organic capex of INR 460 crores; expected to commission INR 1,000 crores each in FY28 and FY29.
- India capex details are in the IR deck; no additional capex planned for Cayman;
- Clinics are expanding: currently 11 clinics in Bangalore, expanding to Calcutta in FY27, aiming to double clinic numbers cautiously balancing cash losses and property acquisition.
2 more points from Narayana Hrudayalaya Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Narayana Hrudayalaya Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Narayana Hrudayalaya Ltd said on order book & pipeline — free account, 30 seconds.
Narayana Hrudayalaya Ltd — Quarterly revenue & net profit
Narayana Hrudayalaya Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 2,594 | 1,475 | +75.9% | 2,151 | +20.6% |
| Operating profit (EBITDA) | 508 | 358 | +41.9% | 365 | +39.2% |
| Operating margin | 20% | 24% | -4 pp | 17% | +3 pp |
| Profit before tax | 288 | 254 | +13.4% | 149 | +93.3% |
| Net profit (PAT) | 224 | 197 | +13.7% | 127 | +76.4% |
| EPS (₹) | 10.96 | 9.65 | +13.6% | 6.20 | +76.8% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.8K Cr, net profit ₹301 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Narayana Hrudaya's management said in earlier quarters
Others in Healthcare Services this season
- Suven Life Sciences (Q4 FY26)
The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su
- Invicta Diagnostic (Q4 FY26)
Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…
- KMC Speciality (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
- Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Narayana Hrudayalaya Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Narayana Hrudayalaya Ltd Q4 FY26 results?
Clinic business to be integrated with hospital business from FY27, reflecting better contribution measurement. Narayana Hrudayalaya is in an expansion phase, investing heavily (USD 100 million capex; INR 3,000 crores planned in India) to fuel growth, which may dilute short-term ROCE/ROE but is expected to be accretive long-term.
What is Narayana Hrudayalaya Ltd share price analysis?
Narayana Hrudayalaya Ltd currently shows a neutral. The stock trades at a P/E of 45.1 with a market cap of ₹38,892 Cr. Investors should review the full earnings analysis for detailed insights.
Is Narayana Hrudayalaya Ltd planning capital expenditure?
FY26 greenfield capex was INR 109 crores, lower than the planned INR 424 crores, mainly due to election-related labor shortages and delays in permissions; FY28 commissioning timeline for Rajarhat, HSR, Raipur, Bangalore still on track.
Keep Narayana Hrudayalaya Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
